Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1617 1619
This examiner grants 60% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18284625 | NON-ELUTABLE ANTIMICROBIAL GLASS COMPOSITION, AND METHOD FOR PREPARING ANTIMICROBIAL GLASS POWDER USING SAME | Final Rejection | LG ELECTRONICS INC. |
| 18183257 | Pharmaceutical Compositions Comprising Sorbitan Esters | Final Rejection | Alkermes Pharma Ireland Limited |
| 18711436 | COSMETIC COMPOSITION FOR CARING FOR THE SKIN | Non-Final OA | L'OREAL |
| 18716697 | Herbicidal Compositions | Non-Final OA | Syngenta Crop Protection AG |
| 17759568 | METHODS OF CONTROLLING OR PREVENTING PANAMA DISEASE IN BANANA PLANTS | Non-Final OA | SYNGENTA CROP PROTECTION AG |
| 18289468 | OILY COSMETIC | Non-Final OA | Shin-Etsu Chemical Co., Ltd. |
| 18626620 | NANO-DELIVERY SYSTEMS COMPRISING MODIFIED LIPIDS AND USE THEREOF | Non-Final OA | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED |
| 18600263 | NANOFIBER AND MICROFIBER HYBRID AEROGELS | Non-Final OA | Board of Regents of the University of Nebraska |
| 18750592 | NANOPARTICLE (NP)-ENHANCED EXPRESSION OF AQUAPORIN-4 CHANNELS AND WATER TRANSPORT IN HUMAN ASTROCYTES | Non-Final OA | The Government of the United States of America, as represented by the Secretary of the Navy |
| 17902949 | ANTI-HEMORRHAGING COMPOSITIONS | Non-Final OA | Ariel Scientific Innovations Ltd. |
| 18711261 | METHODS FOR INTRATUMORAL DELIVERY OF CRISPR/CAS SYSTEMS | Final Rejection | Christiana Care Gene Editing Institute, Inc. |
| 18709362 | TARGETED DRUG DELIVERY-RELEASE AND KILLING OF DRUG RESISTANT TUMORS AND PATHOGENS | Non-Final OA | RUBHU BIOLOGICS, INC. |
| 18053153 | STABILIZED CHEMICAL COMPOSITION | Final Rejection | SYNGENTA PARTICIPATIONS AG |
| 16796990 | ALKALINE DISINFECTING COMPOSITIONS | Final Rejection | GOJO Industries, Inc. |
| 17584125 | Use of short chain fatty acids for the treatment and prevention of diseases and disorders | Final Rejection | Temple University-Of The Commonwealth System of Higher Education |
| 18691330 | A SELF-EMULSIFYING DRUG DELIVERY SYSTEM (SEDDS) OF PUNICIC ACID COMBINED WITH NEUROPROTECTIVE NATURAL PRODUCTS TO DELAY ONSET, PREVENT, OR REVERSE NEURODEGENERATIVE DISEASE | Non-Final OA | TAHIRO INC. |
| 18681308 | USE OF AN ACID WHEY TO STIMULATE THE GERMINATION OF A PLANT POLLEN GRAIN | Non-Final OA | UNIVERSITE DE ROUEN-NORMANDIE |
| 18579422 | METHOD FOR THE PRODUCTION OF GRANULES COMPRISING A MAGNESIUM ION-COMPRISING MATERIAL | Non-Final OA | Omya International AG |
| 18579104 | MALODOR CONTROL COMPOSITIONS AND THEIR USES | Final Rejection | Kalykos LLC |
| 18567913 | MODIFIED CAST METAL OBJECT | Non-Final OA | ARMADILLO METAL COATINGS LTD |
| 18518819 | FORMULATIONS OF DEFERASIROX AND METHODS OF MAKING THE SAME | Final Rejection | AustinPx, LLC |
| 18490224 | SUSTAINED RELEASE INJECTABLE THERAPEUTIC FORMULATIONS USING APROTIC POLAR SOLVENTS | Non-Final OA | Xeris Pharmaceuticals, Inc. |
| 18551835 | A SYNERGISTIC PLANT GROWTH STIMULANT COMPOSITION COMPRISING POTASSIUM MONO/DIFORMATE AND METAL ION COMPOUNDS TO ENHANCED METABOLIC ACTIVITIES IN PLANTS | Non-Final OA | FERTIS INDIA PVT LTD |
| 18470264 | COMPOSITIONS AND METHODS FOR TARGETED RNA DELIVERY | Non-Final OA | Verve Therapeutics, Inc. |
| 18203327 | Method of Antimicrobial and Immune Boosting Activity | Non-Final OA | RRIP, LLC |
| 17769944 | Laminated Type Patch | Final Rejection | MEDRX CO., LTD. |
| 18252018 | DISINFECTANT COMPOSITION FOR SURFACES AND THE PREPARATION THEREOF | Non-Final OA | Prerna GORADIA |
| 16334542 | MICROBEAD COMPOSITIONS AND METHODS FOR DELIVERING AN AGENT | Final Rejection | THE UNIVERSITY OF MEMPHIS RESEARCH FOUNDATION |
| 17714025 | SILK FIBROIN-BASED MICRONEEDLES AND USES THEREOF | Non-Final OA | VAXESS TECHNOLOGIES, INC. |
| 17902214 | ANTIMICROBIAL GLASS COMPOSITIONS, GLASSES AND POLYMERIC ARTICLES INCORPORATING THE SAME | Final Rejection | Glass Technologies Limited |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy